This inventor holds 1 USPTO granted patent. Top assignee: Allergan, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: J Abraham M Le Espiritu: Innovator in Medication Compliance
Introduction
J Abraham M Le Espiritu is a notable inventor based in Oceanside, CA (US). He has made significant contributions to the field of medication compliance through his innovative patent. His work focuses on improving the administration of medication, particularly in the context of titration methods.
Latest Patents
One of his key patents is titled "Memantine titration/compliance dosage methods." This patent describes a titration package and method designed to enhance compliance with a regimen of changing dosages of medication over time. The invention includes a backing with an array of receivers, which consists of multiple columns and rows. Each set of Memantine tablets is organized in a way that allows for easy access and understanding of the dosage schedule. The design incorporates indicia adjacent to the columns and rows to display common days and successive weeks, facilitating better patient adherence to their medication regimen. J Abraham M Le Espiritu holds 1 patent.
Career Highlights
Throughout his career, J Abraham M Le Espiritu has worked with Allergan, Inc., a prominent company in the pharmaceutical industry. His role at Allergan has allowed him to contribute to advancements in medication delivery systems and patient compliance strategies.
Collaborations
He has collaborated with notable colleagues, including Bruce A Firestone and John Jacob Vander Zanden. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective healthcare solutions.
Conclusion
J Abraham M Le Espiritu's contributions to medication compliance through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the pharmaceutical industry and enhance the lives of patients requiring complex medication regimens.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
